Rab22A overexpression is detected in primary breast tumours and associated with decreased overall and metastasis‐free survival (Wang et al., 2014) whereas Rab22A knockdown impairs breast cancer metastasis in an orthotopic mouse model. The gene discussed is RAB22A; the disease is breast neoplasm.